Respiratory Syncytial Virus (RSV)
Vaccine Study

Vaccines help your immune system fight infections and can help prevent serious illnesses, including pneumonia.

Respiratory syncytial virus (RSV) can cause infections in the respiratory tract and lungs. Respiratory syncytial virus is a contagious virus that can affect most people. In mild cases, the virus can cause symptoms similar to the common cold. However, it can cause more serious respiratory illnesses in the elderly, infants, and people with chronic health conditions.

Q&T Research is currently participating in a worldwide RSV Vaccine Study.

No placebo is administered during this study, all eligible participants will receive the RSV vaccine that is under investigation.

You may be eligible if you:

  • 18-49 years of age and 60 years of age and older
  • Have a diagnosis of diabetes, asthma, or chronic obstructive pulmonary disease (COPD)